OS Therapies
(NYSEMKT) OSTX
OS Therapies Financials at a Glance
Market Cap
$85.96M
Revenue (TTM)
$0.00
Net Income (TTM)
-$35.27M
EPS (TTM)
-$1.03
P/E Ratio
-1.88
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$1.83
Volume
4,777
Open
$1.90
Price
$1.83
Volume
4,777
Open
$1.90
Previous Close
$1.83
Daily Range
$1.83 - $1.90
52-Week Range
$1.15 - $2.57
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
1.58 (High)
Price
$1.83
Volume
4,777
Open
$1.90
Previous Close
$1.83
Daily Range
$1.83 - $1.90
52-Week Range
$1.15 - $2.57
Estimated Earnings Date
Aug 14, 2026
OSTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OS Therapies
Industry
Biotechnology
Sector
Health CareEmployees
5
CEO
Paul A. Romness
Website
www.ostherapies.comHeadquarters
Rockville, MD 21638, US
OSTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-914%
Return on Capital
4%
Return on Assets
-5%
Earnings Yield
-53.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$85.96M
Shares Outstanding
44.54M
Volume
4.78K
Avg. Volume
718.53K
Financials (TTM)
Gross Profit
-$363.09K
Operating Income
-$28.71M
EBITDA
-$28.39M
Operating Cash Flow
-$14.24B
Capital Expenditure
-$466.42K
Free Cash Flow
-$14.24B
Cash & ST Invst.
$269.83M
Total Debt
$0.00
OS Therapies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$124.94K
N/A
Gross Margin
0.00%
N/A
Market Cap
$85.96M
N/A
Market Cap/Employee
$21.49M
N/A
Employees
4
N/A
Net Income
-$10.40M
-168.2%
EBITDA
-$10.20M
-163.1%
Quarterly Fundamentals
Total Cash
$917.55M
+30783.5%
Total Debt
$1.34B
N/A
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.34B
N/A
Return on Assets
-4.83%
N/A
Return on Invested Capital
3.51%
N/A
Free Cash Flow
-$4.56M
-27.1%
Operating Cash Flow
-$4.56M
-32.6%